This compound is primarily used in pharmaceutical research and development, particularly in the study of central nervous system (CNS) disorders. It serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of drugs targeting neurological conditions, such as depression, anxiety, or other mood-related disorders. Its structure, featuring a cyclopropyl group and a fluorophenyl moiety, is designed to interact with specific receptors in the brain, potentially enhancing therapeutic efficacy and selectivity. Additionally, it may be investigated for its potential in treating neurodegenerative diseases or as a component in novel psychotropic medications. Its hydrochloride form ensures stability and solubility, making it suitable for formulation into various drug delivery systems.